Comments

Annovis Bio Stock Price, Quotes and Forecasts

Q: What sector and industry does Annovis Bio (ANVS) operate in?

Annovis Bio is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.

ANVSNYSE

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Annovis Bio (ANVS) Forecast

News Earnings Annovis Bio (ANVS) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Annovis Bio Stock Price, Quotes and Forecasts | NYSE:ANVS | Benzinga

Explore Annovis Bio stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ANVS.

Open	$3.34
Close	-
Volume / Avg.	788.23K / 411.83K
Day Range	$2.98 - $3.36
52 Wk Range	1.11 - 17.88
Market Cap	$61.28M
P/E Ratio	-
Dividend Yield	-
Exchange	NYSE
RSI	76
Short Interest	11.73%
Days to Cover	5.6

Recent News

Levi Strauss To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Thursday

Avi Kapoor

Editas Q2 Earnings & Revenues Miss Estimates, Stock Down

Editas Medicine, Inc. (NASDAQ: EDIT) incurred a loss of 82 cents per share in the second quarter of 2024, wider than the Zacks Consensus Estimate of a loss of 69 cents. The company had reported a loss of 56 cents per share in the year-ago quarter.

Zacks

Immutep Up as Combo Therapy Meets Carcinoma Study Goals

Immutep Limited (NASDAQ: IMMP) jumped 14.9% after it announced positive results from cohort B of the late-stage TACTI-003 (KEYNOTE-PNC-34) study.

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$3.34
Close	-
Volume / Avg.	788.23K / 411.83K
Day Range	$2.98 - $3.36
52 Wk Range	1.11 - 17.88
Market Cap	$61.28M
P/E Ratio	-
Dividend Yield	-
Exchange	NYSE
RSI	76
Short Interest	11.73%
Days to Cover	5.6

About Annovis Bio Inc

Sector

Health Care

Industry

Biotechnology

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Annovis Bio (ANVS) stock?

You can purchase shares of Annovis Bio (NYSE:ANVS) through any online brokerage.

View our list of the best stock brokerages

Who are Annovis Bio (ANVS) competitors?

Other companies in Annovis Bio’s space includes: Serina Therapeutics (AMEX:SER), Kalaris Therapeutics (NASDAQ:KLRS), Skye Bioscience (NASDAQ:SKYE), Gain Therapeutics (NASDAQ:GANX) and Citius Oncology (NASDAQ:CTOR).

What is the forecast, or price target, for Annovis Bio (ANVS) stock?

Annovis Bio has a consensus price target of $33.71.

What is the current price for Annovis Bio (ANVS)?

The stock price for Annovis Bio (NYSE: ANVS) is $3.145 last updated June 5, 2025 at 1:30 PM EDT.

Does Annovis Bio (ANVS) pay a dividend?

There are no upcoming dividends for Annovis Bio.

When is Annovis Bio (NYSE:ANVS) reporting earnings?

Annovis Bio’s Q2 earnings are confirmed for Thursday, August 14, 2025.

Is Annovis Bio (ANVS) going to split?

There is no upcoming split for Annovis Bio.

What sector and industry does Annovis Bio (ANVS) operate in?

Annovis Bio is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.